Neuroimaging Correlates of Treatment Response with Psychedelics in Major Depressive Disorder: A Systematic Review
Preliminary evidence supports the use of psychedelics for major depressive disorder (MDD). However, less attention has been given to the neural mechanisms behind their effects. We conducted a systematic review examining the neuroimaging correlates of antidepressant response following psychedelic int...
Main Authors: | Sarah Kuburi, Anne-Marie Di Passa, Vanessa K. Tassone, Raesham Mahmood, Aleksandra Lalovic, Karim S. Ladha, Katharine Dunlop, Sakina Rizvi, Ilya Demchenko, Venkat Bhat |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-07-01
|
Series: | Chronic Stress |
Online Access: | https://doi.org/10.1177/24705470221115342 |
Similar Items
-
Efficacy of ketamine for comorbid depression and acute or chronic pain: A systematic review
by: Aksharra Balachandran, et al.
Published: (2022-10-01) -
Local Injection for Treating Mood Disorders (LIFT-MOOD): A Pilot Feasibility RCT of Stellate Ganglion Block for Treatment-Resistant Depression
by: David Sussman, et al.
Published: (2023-03-01) -
The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies
by: J. H. Shepherd, et al.
Published: (2023-03-01) -
Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder
by: Sophie R. Vaccarino, et al.
Published: (2024-01-01) -
Psychedelics in therapy
by: Thomas Cardoso de Oliveira, et al.
Published: (2023-09-01)